{
    "Contributors": [
        "Ishani Mondal"
    ],
    "Source": [
        "ade_corpus_v2"
    ],
    "URL": [
        "https://github.com/trunghlt/AdverseDrugReaction/tree/master/ADE-Corpus-V2"
    ],
    "Categories": [
        "Text Categorization"
    ],
    "Reasoning": [],
    "Definition": [
        "The task is to read medical case reports extracted from MEDLINE and classify them as non-adverse drug events or adverse drug events. An adverse drug reaction is a harmful or unpleasant reaction resulting from the use of a medical product."
    ],
    "Input_language": [
        "English"
    ],
    "Output_language": [
        "English"
    ],
    "Instruction_language": [
        "English"
    ],
    "Domains": [
        "Biology -> Clinical Knowledge",
        "Healthcare"
    ],
    "Positive Examples": [
        {
            "input": "A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy.",
            "output": "adverse drug event",
            "explanation": "Here, the child is facing some trouble after undergoing a particular therapy, thereby causing an adverse effect of the therapy."
        },
        {
            "input": "She responded well to Sodium valproate.",
            "output": "non-adverse drug event",
            "explanation": "This is a pretty straightforward remark because it is related to filing taxes with minimal stress and is unrelated to irony or sarcasm."
        }
    ],
    "Negative Examples": [
        {
            "input": "The patient suffered from breathing trouble after taking azithromycin.",
            "output": "serious",
            "explanation": "You are expected to return \"adverse drug event\" or \"non-adverse drug event\". This should be classified as adverse drug event because the patient suffers from an issue after taking in a particular drug."
        },
        {
            "input": "The patient is feeling better at the hospital.",
            "output": "wellness",
            "explanation": "You are expected to return \"adverse drug event\" or \"non-adverse drug event\". This should be classified as non-adverse drug event because no harmful after-effect of any medical intervention has been mentioned."
        },
        {
            "input": "A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy.",
            "output": "non-adverse drug event",
            "explanation": "Here, the child is facing some trouble after undergoing a particular therapy, thereby causing an adverse effect of the therapy. So, it needs to be tagged as adverse drug event instead of non-adverse drug event."
        }
    ],
    "Instances": [
        {
            "id": "task1495-0244aa77adb04afca8ffe7379f730ad5",
            "input": "Echocardiography revealed severe, global left-ventricular dysfunction.",
            "output": [
                "non-adverse drug event"
            ]
        },
        {
            "id": "task1495-305c9f78c3ea4be191ef8786e367b23c",
            "input": "Ten days after itraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-9600a12a162142528a52547387c00c7b",
            "input": "In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross-reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3-year follow-up period after discontinuation of the mequitazine.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-75dbd38916d345e6a3c4c6c72212a4fd",
            "input": "Anti-tuberculous drugs had been stopped on the 2nd day of therapy due to development of optic neuritis secondary to ethambutol administration at another hospital.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-18e2a810cc714e3cbafbcf352e719bb0",
            "input": "The increasing prevalence of methamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of methamphetamine-related keratitis.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-c5ea474a5d964fa8b5bafbcf9929cf03",
            "input": "The tyrosine kinase activity and its effects represent a potential pharmacologic target of tyrosine kinase inhibitors, such as imatinib.",
            "output": [
                "non-adverse drug event"
            ]
        },
        {
            "id": "task1495-d720481ff621442984db832fd27e7b52",
            "input": "CONCLUSIONS: Physicians should be aware that drug-induced AIN can be associated with proton-pump inhibitors.",
            "output": [
                "non-adverse drug event"
            ]
        },
        {
            "id": "task1495-8551e857f26f42b68b1a8374daa42829",
            "input": "Cerebrospinal fluid examination showed albuminocytologic dissociation (total protein concentration 118 mg/dl and 152 mg/dl, respectively).",
            "output": [
                "non-adverse drug event"
            ]
        }
    ],
    "Instance License": [
        "Unknown"
    ]
}